A Diels-Alder polymer platform for thermally enhanced drug release toward efficient local cancer chemotherapy
Source abstract
Abstract
-(3-maleimidopropionyloxy)succinimide as a linker by DA reaction (PFMA-L-GEM). The conversion rate of the DA reaction was found to be approximately 60% at room temperature for 120 h. The reversible deconstruction of the DA covalent bond in retro Diels-Alder (rDA) reaction was confirmed by proton nuclear magnetic resonance, and the reaction was significantly accelerated at 90 °C. A PFMA-LGEM film containing magnetic nanoparticles (MNPs) was prepared for thermally enhanced release of the drug via the rDA reaction. Drug release was initiated by heating MNPs by alternating magnetic field. This enables local heating within the film above the rDA reaction temperature while maintaining a constant surrounding medium temperature. The MNPs/PFMA-L-GEM film decreased the viability of pancreatic cancer cells by 49% over 24 h. Our results suggest that DA/rDA-based thermally enhanced drug release systems can serve as a local drug release platform and deliver the target drug within locally heated tissue, thereby improving the therapeutic efficiency and overcoming the side effects of conventional drugs used to treat pancreatic cancer.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Synthetic Organic Chemistry Methods · Sphingolipid Metabolism and Signaling · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Research Center for Functional Materials, National Institute for Materials Science (NIMS), Tsukuba, Japan
Graduate School of Pure and Applied Sciences, University of Tsukuba, Tsukuba, Japan
Department of Radiation Oncology, University of Tsukuba Hospital, Tsukuba, Japan
Graduate School of Advanced Engineering, Department of Materials Science and Technology, Tokyo University of Science, Katsushika-ku, Japan
Funding
JSPS KAKENHI Grant-in-Aid for Scientific Research · Grant-in-Aid for Transformative Research Areas
References (33)
Show source-provided references
1. American Cancer Society. Cancer Facts & Figures 2020.
2. 10.1158/0008-5472.CAN-12-222510.1158/0008-5472.CAN-12-2225 ↗
3. 10.1016/j.jconrel.2011.11.03110.1016/j.jconrel.2011.11.031 ↗
4. 10.1159/00044400410.1159/000444004 ↗
5. 10.1159/00014891410.1159/000148914 ↗
6. 10.1093/neuonc/5.2.7910.1093/neuonc/5.2.79 ↗
7. 10.1021/acsbiomaterials.6b0058110.1021/acsbiomaterials.6b00581 ↗
8. 10.3390/fib304047810.3390/fib3040478 ↗
9. 10.1088/1468-6996/13/6/06420310.1088/1468-6996/13/6/064203 ↗
10. 10.1016/j.actbio.2021.01.02210.1016/j.actbio.2021.01.022 ↗
11. 10.1109/TNANO.2017.277021710.1109/TNANO.2017.2770217 ↗
12. 10.1016/j.copbio.2016.03.00910.1016/j.copbio.2016.03.009 ↗
13. 10.3390/polym1009101810.3390/polym10091018 ↗
14. 10.3390/polym1003023110.3390/polym10030231 ↗
15. Okada T · Materials · 2016 · 9 · 1
16. 10.1166/jnn.2015.1123310.1166/jnn.2015.11233 ↗
17. 10.1002/adhm.20190010210.1002/adhm.201900102 ↗
18. 10.1002/adfm.20130074610.1002/adfm.201300746 ↗
19. 10.3390/ijms2205254210.3390/ijms22052542 ↗
20. 10.1016/j.ejpb.2015.06.00710.1016/j.ejpb.2015.06.007 ↗
21. 10.1016/j.jconrel.2017.09.02710.1016/j.jconrel.2017.09.027 ↗
22. 10.1016/j.colsurfb.2016.11.00510.1016/j.colsurfb.2016.11.005 ↗
23. 10.1002/pola.2219510.1002/pola.22195 ↗
24. 10.1016/j.ijbiomac.2019.09.02710.1016/j.ijbiomac.2019.09.027 ↗
25. 10.1021/jacs.0c0707710.1021/jacs.0c07077 ↗
26. 10.1016/j.ica.2019.01.01410.1016/j.ica.2019.01.014 ↗
27. 10.1002/marc.20035001310.1002/marc.200350013 ↗
28. 10.1039/c3cs60044k10.1039/c3cs60044k ↗
29. 10.1016/j.progpolymsci.2012.04.00210.1016/j.progpolymsci.2012.04.002 ↗
30. 10.1039/C5RA01185J10.1039/C5RA01185J ↗
31. 10.1016/j.carbpol.2020.11647710.1016/j.carbpol.2020.116477 ↗
32. 10.1080/0265673080265703610.1080/02656730802657036 ↗
33. 10.1021/mp300370t10.1021/mp300370t ↗